Sort
130,381 grants matching “hiv”
Universal basic income and structural racism in the US South: Differences in health service utilization between older African American men with and without experiences of recent incarceration
$1,138,487Brooke E.e. Montgomery · Univ Of Arkansas For Med Scis · R01 · FY2023 · MD
Critical Path Project: Mapp66, a Multi-antibody Prevention Product
$1,138,391Kevin John Whaley · Boston University Medical Campus · U19 · FY2013 · AI
An integrated intervention using a pill ingestible sensor system to trigger actions on multifaceted social and behavioral determinants of health among PLWH
$1,138,343Honghu Liu · University Of California Los Angeles · R01 · FY2025 · MD
Anti-HIV Neuroimmunomodulatory Therapy with Neurokinin-1 (NK1-R) Antagonists
$1,138,312Steven Daniel Douglas · Children'S Hosp Of Philadelphia · U01 · FY2010 · MH
COPTIC HOSPITAL/UNIVERSITY OF WASHINGTON COLLABORATIVE HIV-1 CARE PROGRAM
$1,138,180Paul Yowakim · Coptic Orthodox Church · U2G · FY2013 · PS
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$1,138,006Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Nmr Studies Of The Regulation Of Cell Signaling
$1,137,964Nico Tjandra · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Pediatric AIDS Clinical Trials Group
$1,137,764St. Jude Children'S Research Hospital · U01 · FY2002 · AI
HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM
$1,137,711Cecilia M Shikuma · University Of Hawaii At Manoa · U01 · FY2006 · AI
Neuronal Immunity in HIV Dementia
$1,137,512Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2007 · NS
Structural biology and immunogen design
$1,137,348Stephen C Harrison · Boston Children'S Hospital · P01 · FY2019 · AI
Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)
$1,137,273Karen L Cropsey · University Of Alabama At Birmingham · P01 · FY2022 · AA
Signal Pathways Modulating HIV-1-induced Injury in CNS
$1,137,262Temple University · P01 · FY2004 · NS
Vaccine and Treatment Evaluation Units
$1,137,245Nadine Georges Rouphael · Emory University · UM1 · FY2024 · AI
Heterodimeric IL-15 in Cancer Immunotherapy
$1,137,140George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
PATHOGENESIS OF HIV-ASSOCIATED NEPHROPATHY
$1,137,098Mount Sinai School Of Medicine Of Nyu · P01 · FY2003 · DK
URBAN CONGREGATIONS' CAPACITY FOR HIV PREVENTION & CARE
$1,136,889Kathryn Pitkin Derose · Rand Corporation · R01 · FY2009 · HD
GENDER EFFECTS ON HIV BIOLOGY
$1,136,800J. David Gladstone Institutes · P01 · FY2001 · HD
Administrative Core
$1,136,769Simon Alexander Mallal · Vanderbilt University Medical Center · P30 · FY2016 · AI
HIV Vaccine Design and Development Teams (HVDDT)
$1,136,715 · N01 · FY2007 · AI
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVVDT)
$1,136,715Jeffrey D Chulay · · N01 · FY2007 · AI
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$1,136,693Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Tracking HIV Infection and Alcohol Abuse CNS Comorbidity with Neuroimaging
$1,136,537Adolf Pfefferbaum · Sri International · U01 · FY2016 · AA
NIAID Preclinical Development Support - Development of clade C Vaccine
$1,136,533Jon Carl Mirsalis · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study
$1,136,478Linda A Teplin · Northwestern University At Chicago · R01 · FY2007 · DA